Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Egyptian MTA vs Biodentine vs Calcium Hydroxide for Indirect Pulp Capping
NCT06683833Phase 4Recruiting
- Sponsor
- Cairo University
- Start
- Sep 2025
- Primary completion
- May 2026
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Egyptian MTA, Biodentine in dental caries, sponsored by Cairo University. Started Sep 2025; status: recruiting.
02
Drugs
Egyptian MTABiodentine
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT06683833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06683833.